Given that CD47 is the downstream effector molecule of SMYD3 involved in orchestrating the inhibitory immune microenvironment in ccRCC, we explored the correlation between CD47 mRNA expression and Th2 cells in ccRCC. This evidence concerns the gene CD47 and nonpapillary renal cell carcinoma.